Form 4: BioCardia CEO Peter Altman Buys 500 Shares of Common Stock
SEC Form 4
BioCardia's President and CEO, Peter Altman, recently purchased 500 shares of the company's common stock at an average price of $3.52 per share.
Summary
- On June 14, 2024, Peter Altman, the President and CEO of BioCardia, Inc., acquired 500 shares of common stock.
- The purchase was made at a price of $3.52 per share.
- Following the transaction, Altman directly owns 38,745 shares of BioCardia's common stock.
- The transaction was executed in multiple trades ranging from $3.48 to $3.58 per share, with the reported price reflecting the weighted average.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but the quantity is relatively small.
Positives
- The CEO's purchase of company stock may signal confidence in BioCardia's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The purchase may have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of the transaction: Peter Altman purchased 500 shares of BioCardia's common stock. |
| 06/17/2024 | Date of signature on the SEC Form 4 filing. |
Keywords
BioCardia, Peter Altman, BCDA, Insider Trading, Stock Purchase, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.